Report      Database

    Breast Cancer Screening Market & Forecast (Mammography, MRI & Ultrasound) Global - 2nd edition

    Date: 07 Jul, 2017              Type: Diagnostics              Pages: 255

    Breast Cancer Screening Market & Forecast (Mammography, MRI & Ultrasound) Global - 2nd edition
    • Electronic Access - Single User License
      $1,550.00
    • CD-ROM Mail Delivery
      $1,650.00
    • Hard-copy Mail Delivery
      $1,750.00
    • Electronic Access - Multi User License
      $2,350.00

    Get 10% Free Customization in this Report

    Breast Cancer Screening Market is expected to be more than US$ 20 Billion by 2022. Breast cancer is the 2nd most common cancer among the women in the world. Number of breast cancer cases in less developed regions is higher than developed regions. Breast cancer mammography screening population is mainly dominated by larger women populous countries such as United States, China and Japan. Worldwide Breast Cancer Ultrasound and MRI Screening Market is also growing year on year. 


    Mammography is the Common Test for Breast Cancer Screening 

    Mammogram is one of the most popular breast cancer screening methods. It does not prevent from the cancer but it can save lives by finding cancer as early as possible. Most of the countries, mammogram is incorporated with government breast cancer screening program. In the Less developed and developing countries, mammogram is on the way to be adopted by government.  


    Breast Cancer MRI Screening Market is Mostly Dominated by the Developed Countries

    Breast cancer MRI screening market is mostly dominated by the developed countries as it is a costly procedure. United States, France and Germany control over half of the total breast cancer MRI screening market in 2016. United Kingdom, Italy, Canada are other major market for this test.


    Low Awareness in Low and Middle Income Countries 

    Breast cancer awareness in low and middle income countries is low. In these countries, government has no proper program for breast cancer screening and due to lack of government support, women in these countries not aware about the breast cancer as a deadly disease. They are trying to hide their problem due to social and cultural issues. Non-availability of lady doctors is also playing a major role to increase the disease in the region.

     

    Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide is the 4th report published by Renub Research on Breast Cancer Screening Market. The report analyzes the Global market for Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market. This report studies separate comprehensive analytics for the 20 countries: United States, Canada, European Countries (United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway and Switzerland), Asian countries (India, China, Japan, Korea, Singapore, Thailand, Malaysia and Brazil), Australia and New Zealand. 
     
    This
    255 page report with 252 Figures and 14 Tables provides a complete analysis of top 20 countries of Global Breast Cancer Screening Market. All the 20 countries in the report have been studied from 7 viewpoints.

    •    Worldwide Breast Cancer Screening Market and Forecast 
    •    Countries Breast Cancer Mammography Screening Population Scenario and Forecast 
    •    Countries Breast Cancer MRI & Ultrasound Screening Population Scenario and Forecast 
        Countries Breast Cancer Mammography Screening Market and Forecast 
    •    Countries Breast Cancer MRI Screening Market and Forecast 
    •    Countries Breast Cancer Ultrasound Screening Market and Forecast 
        Countries Breast Cancer Screening Market and Forecast 


    All the 20 Countries Studied in the Report are as Follows 

     
    1.    United States
    2.    Canada 
    3.    United Kingdom
    4.    France
    5.    Germany
    6.    Italy
    7.    Spain
    8.    Netherlands
    9.    Norway
    10.    Switzerland
    11.    India
    12.    China
    13.    Japan
    14.    Korea
    15.    Singapore
    16.    Thailand
    17.    Malaysia
    18.    Brazil
    19.    Australia
    20.    New Zealand

     

     

    Press Release - Breast Cancer Screening: Today's Obstacle and Tomorrow's promise

    Breast cancer screening is conceded out to detect cancer in its premature stages and ensure timely treatment of the patients. A bunch of innovative medicines, as well as tests for the cancer patients with an extensive multiplicity of tumor types and based on capable new mechanisms of action, has enhanced the enthusiasm about prospects for major approaches in breast cancer treatment. The large number of new medicines at present are in scientific development or under dogmatic review recommends.

    Mammogram, screening, MRI, Ultrasound do not prevent breast cancer but they are helpful in early detection of breast cancer. Renub Research predicts that by the year 2022, Breast Cancer Screening Market is projected to be more than US$ 20 Billion


    Types of Breast Cancer Screening Tests

    Mammogram

    Mammogram is an X-ray of the breast. It could be the best way to find breast cancer at early stages. The Mammogram could not prevent from cancer but it can save lives by discovering cancer at earliest. In most developed nations, the mammogram is integrated with government breast cancer screening program while in less developed nations; mammogram is on prospects to be adopted by the government. 


    MRI Screening Market

    In a breast MRI screening Test the method comprises magnets and radio waves to take the pictures of the breast. It is used along with mammogram to screen women who are at high risk for breast cancer. Mainly the developed nations led the breast cancer MRI screening test as it is a very effective procedure. The nations like Germany, United States, and France held control over half of the market in 2016. The other nations who control the market in MRI screening test were Canada, Italy and United Kingdom.  


    Ultrasound Test

    Ultrasound is an imaging test which delivers high- frequency sound waves through the breast and converts into images on viewing screen. In this, no radiation is involved. Screening test for breast cancer is not using Ultrasound on its own either it is used to complement other screening tests. Though, the use of ultrasound in screening is linked with a high rate of both positive and negative outcomes.


    Breast Cancer Screening Market and Population: Survey

    The United States is the largest market for breast cancer screening market. China and Germany are at number third and second spot competing for the maximum number of shares in the market. The United Kingdom is at number fourth spot followed by Italy for the market share in the breast cancer screening.


    In terms of breast cancer screening population, the nations like the United States, the United Kingdom, China, Japan and Germany captures almost 60 percent share of the global breast cancer screening in the year 2016. In addition, the nations like Spain, Italy, France, India and South Korea are the other nations who contribute to the breast cancer screening population.


    A look at Global spending on Cancer

    Global spending on cancer medicines – including supportive care and therapeutic treatments, and measured at ex-manufacturer prices not reflecting off-invoice discounts, rebates and patient access schemes reached US$ 100 Billion, up from US$ 75 Billion five years earlier.

    •    Since 2011, In the main developed markets, a sharp growth in the volume of protected brands and considerable new product launches have been the main drivers of spending expansion, while the effects of patent expiries have moderated over the years.

    •    On a per capita basis, spending reached US$ 99 in 2014, up from US$ 71 in 2010 on therapeutic cancer medicines in the United States.

    •    Oncology drugs spending has risen marginally as a level of aggregate medication spending in the course of recent years in all regions, most strikingly in the EU5 nations where oncology now speaks to 14.7% of aggregate medication spending, up from 13.3% out of 2010, while the U.S. has seen oncology increment all the more humbly from 10.7% to 11.3% of aggregate medication spending over a similar period. 

    •    Future spending on oncology medicines through 2018 are relied upon to be in the 6-8% territory, contrasted with 6.5% in the course of recent years as developing interest and new treatment choices are balanced to some degree by new rivalry from bio similar and small molecule generics following patent expiries.
     

     

    Content from Old Report is given below: 
    The user can buy this report in Chapters from Purchase by Chapter section given above

    Breast cancer is the most common cancer among women in both the developed and developing world. Worldwide Breast Cancer Screening Market was in double digit Billion US$ for 2013. United States is the leading market for breast cancer screening globally. China is expected to maintain its 2nd position in the forecasting period due to hefty number of breast cancer cases.  Worldwide Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market are also growing year on year. 

    Worldwide Breast Cancer Screening population is expected to be little less than 250 Million by 2018. For 2013; China contributes the largest pool of patients followed by United States. Both these countries control double digit population share. Brazil, Japan and Germany occupy the 3rd, 4th, & 5th position respectively.     

    This is our 4th report on Cancer Sector. Renub Research study titled “Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide” analyzes the worldwide market for breast cancer mammography screening market, Breast cancer MRI screening market and breast cancer ultrasound screening market. This report studies separate comprehensive analytics for the 20 countries: United States, Canada, European Countries (United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway and Switzerland), Asian countries (India, China, Japan, Korea, Singapore, Thailand, Malaysia and Brazil), Australia and New Zealand. 

    Annual estimates and forecast are provided for the period of 2014 through 2018. A six year historic analysis is also provided for these markets. This 258 page report with 252 Figures and 14 Tables provides a complete analysis of top 20 countries of worldwide breast cancer screening market. All the 20 countries in the report have been studied from 7 viewpoints.

    • Countries Breast Cancer Mammography Screening Population Scenario and Forecast 
    • Countries Breast Cancer MRI & Ultrasound Screening Population Scenario and Forecast 
    • Countries Breast Cancer Mammography Screening Market and Forecast 
    • Countries Breast Cancer MRI Screening Market and Forecast 
    • Countries Breast Cancer Ultrasound Screening Market and Forecast 
    • Countries Breast Cancer Screening Market and Forecast 
    • Worldwide Breast Cancer Screening Market and Forecast 

    All the 20 Countries Studied In the Report are as Follows

    1. United States
    2. Canada 
    3. United Kingdom
    4. France
    5. Germany
    6. Italy
    7. Spain
    8. Netherlands
    9. Norway
    10. Switzerland
    11. India
    12. China
    13. Japan
    14. Korea
    15. Singapore
    16. Thailand
    17. Malaysia
    18. Brazil
    19. Australia
    20. New Zealand

    Data Sources
     
    This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts. 

    Primary sources include industry surveys and telephonic interviews with industry experts. 
     
    Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases. 

    1.    Executive Summary 


    2.    Worldwide Screening Population Analysis
     2.1    Worldwide Breast Cancer Mammography Screening Population & Forecast

    2.2    Worldwide Breast Cancer MRI & Ultrasound Screening Population & Forecast
     

    3.    Worldwide Breast Cancer Screening Market Analysis
     3.1    Worldwide Breast Cancer Screening Market & Forecast
     3.1.1    Worldwide Breast Cancer Mammography Screening Market & Forecast
     3.1.2    Worldwide Breast Cancer MRI Screening Market & Forecast
     3.1.3    Worldwide Breast Cancer Ultrasound Screening Market & Forecast


    4.    Worldwide Breast Cancer Screening Population & Market Share Analysis
     4.1    Worldwide Breast Cancer Mammography Screening Population Share & Forecast

    4.2    Worldwide Breast Cancer MRI & Ultrasound Screening Population Share & Forecast
     

    5.    Worldwide Breast Cancer Screening Market Share Analysis
     5.1    Worldwide Breast Cancer Screening Market Share & Forecast

    5.2    Worldwide Breast Cancer Mammography Screening Market Share & Forecast

    5.3    Worldwide Breast Cancer MRI Screening Market Share & Forecast

    5.4    Worldwide Breast Cancer Ultrasound Screening Market Share & Forecast


    6.    United Kingdom
     6.1    United Kingdom Breast Cancer Mammography Screening Population & Forecast

    6.2    United Kingdom Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    6.3    United Kingdom Breast Cancer Screening Market & Forecast
     6.3.1    United Kingdom Breast Cancer Mammography Screening Market & Forecast
     6.3.2    United Kingdom Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     6.3.3    United Kingdom Breast Cancer Ultrasound Screening Market & Forecast
     

    7.    France
     7.1    France Breast Cancer Mammography Screening Population & Forecast

    7.2    France Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    7.3    France Breast Cancer Screening Market & Forecast
     7.3.1    France Breast Cancer Mammography Screening Market & Forecast
     7.3.2    France Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     7.3.3    France Breast Cancer Ultrasound Screening Market & Forecast 


    8.    Germany
     8.1    Germany Breast Cancer Mammography Screening Population & Forecast

    8.2    Germany Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    8.3    Germany Breast Cancer Screening Market & Forecast
     8.3.1    Germany Breast Cancer Mammography Screening Market & Forecast
     8.3.2    Germany Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     8.3.3    Germany Breast Cancer Ultrasound Screening Market & Forecast
     

    9.    Italy
     9.1    Italy Breast Cancer Mammography Screening Population & Forecast

    9.2    Italy Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    9.3    Italy Breast Cancer Screening Market & Forecast
     9.3.1    Italy Breast Cancer Mammography Screening Market & Forecast
     9.3.2    Italy Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     9.3.3    Italy Breast Cancer Ultrasound Screening Market & Forecast

     
    10.    Spain
     10.1    Spain Breast Cancer Mammography Screening Population & Forecast

    10.2    Spain Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    10.3    Spain Breast Cancer Screening Market & Forecast
     10.3.1    Spain Breast Cancer Mammography Screening Market & Forecast
     10.3.2    Spain Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     10.3.3    Spain Breast Cancer Ultrasound Screening Market & Forecast


    11.    Switzerland
     11.1    Switzerland Breast Cancer Mammography Screening Population & Forecast

    11.2    Switzerland Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    11.3    Switzerland Breast Cancer Screening Market & Forecast
     11.3.1    Switzerland Breast Cancer Mammography Screening Market & Forecast
     11.3.2    Switzerland Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     11.3.3    Switzerland Breast Cancer Ultrasound Screening Market & Forecast


    12.    Norway
     12.1    Norway Breast Cancer Mammography Screening Population & Forecast

    12.2    Norway Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    12.3    Norway Breast Cancer Screening Market & Forecast
     12.3.1    Norway Breast Cancer Mammography Screening Market & Forecast
     12.3.2    Norway Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     12.3.3    Norway Breast Cancer Ultrasound Screening Market & Forecast


    13.    Netherlands
     13.1    Netherlands Breast Cancer Mammography Screening Population & Forecast

    13.2    Netherlands Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    13.3    Netherlands Breast Cancer Screening Market & Forecast
     13.3.1    Netherlands Breast Cancer Mammography Screening Market & Forecast
     13.3.2    Netherlands Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     13.3.3    Netherlands Breast Cancer Ultrasound Screening Market & Forecast


    14.    United States
     14.1    United States Breast Cancer Mammography Screening Population & Forecast

    14.2    United States Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    14.3    United States Breast Cancer Screening Market & Forecast
     14.3.1    United States Breast Cancer Mammography Screening Market & Forecast
     14.3.2    United States Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     14.3.3    United States Breast Cancer Ultrasound Screening Market & Forecast


    15.    Canada
     15.1    Canada Breast Cancer Mammography Screening Population & Forecast

    15.2    Canada Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    15.3    Canada Breast Cancer Screening Market & Forecast
     15.3.1    Canada Breast Cancer Mammography Screening Market & Forecast
     15.3.2    Canada Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     15.3.3    Canada Breast Cancer Ultrasound Screening Market & Forecast


    16.    Japan
     16.1    Japan Breast Cancer Mammography Screening Population & Forecast

    16.2    Japan Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    16.3    Japan Breast Cancer Screening Market & Forecast
     16.3.1    Japan Breast Cancer Mammography Screening Market & Forecast
     16.3.2    Japan Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     16.3.3    Japan Breast Cancer Ultrasound Screening Market & Forecast


    17.    Korea
     17.1    Korea Breast Cancer Mammography Screening Population & Forecast

    17.2    Korea Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    17.3    Korea Breast Cancer Screening Market & Forecast
     17.3.1    Korea Breast Cancer Mammography Screening Market & Forecast
     17.3.2    Korea Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     17.3.3    Korea Breast Cancer Ultrasound Screening Market & Forecast


    18.    Singapore
     18.1    Singapore Breast Cancer Mammography Screening Population & Forecast

    18.2    Singapore Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    18.3    Singapore Breast Cancer Screening Market & Forecast
     18.3.1    Singapore Breast Cancer Mammography Screening Market & Forecast
     18.3.2    Singapore Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     18.3.3    Singapore Breast Cancer Ultrasound Screening Market & Forecast


    19.    Malaysia
     19.1    Malaysia Breast Cancer Mammography Screening Population & Forecast

    19.2    Malaysia Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    19.3    Malaysia Breast Cancer Screening Market & Forecast
     19.3.1    Malaysia Breast Cancer Mammography Screening Market & Forecast
     19.3.2    Malaysia Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     19.3.3    Malaysia Breast Cancer Ultrasound Screening Market & Forecast


    20.    India
     20.1    India Breast Cancer Mammography Screening Population & Forecast

    20.2    India Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    20.3    India Breast Cancer Screening Market & Forecast
     20.3.1    India Breast Cancer Mammography Screening Market & Forecast
     20.3.2    India Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     20.3.3    India Breast Cancer Ultrasound Screening Market & Forecast


    21.    China
     21.1    China Breast Cancer Mammography Screening Population & Forecast

    21.2    China Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    21.3    China Breast Cancer Screening Market & Forecast
     21.3.1    China Breast Cancer Mammography Screening Market & Forecast
     21.3.2    China Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     21.3.3    China Breast Cancer Ultrasound Screening Market & Forecast


    22.    Thailand
     22.1    Thailand Breast Cancer Mammography Screening Population & Forecast

    22.2    Thailand Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    22.3    Thailand Breast Cancer Screening Market & Forecast
     22.3.1    Thailand Breast Cancer Mammography Screening Market & Forecast
     22.3.2    Thailand Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     22.3.3    Thailand Breast Cancer Ultrasound Screening Market & Forecast


    23.    Brazil
     23.1    Brazil Breast Cancer Mammography Screening Population & Forecast

    23.2    Brazil Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    23.3    Brazil Breast Cancer Screening Market & Forecast
     23.3.1    Brazil Breast Cancer Mammography Screening Market & Forecast
     23.3.2    Brazil Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     23.3.3    Brazil Breast Cancer Ultrasound Screening Market & Forecast


    24.    Australia
     24.1    Australia Breast Cancer Mammography Screening Population & Forecast

    24.2    Australia Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    24.3    Australia Breast Cancer Screening Market & Forecast
     24.3.1    Australia Breast Cancer Mammography Screening Market & Forecast
     24.3.2    Australia Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     24.3.3    Australia Breast Cancer Ultrasound Screening Market & Forecast


    25.    New Zealand
     25.1    New Zealand Breast Cancer Mammography Screening Population & Forecast

    25.2    New Zealand Breast Cancer Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population & Forecast

    25.3    New Zealand Breast Cancer Screening Market & Forecast
     25.3.1    New Zealand Breast Cancer Mammography Screening Market & Forecast
     25.3.2    New Zealand Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market & Forecast
     25.3.3    New Zealand Breast Cancer Ultrasound Screening Market & Forecast


    26.    Breast Cancer Screening Market Growth Drivers
     26.1    Increasing Women’s Breast Cancer Care, Treatment & Awareness Initiatives Globally

    26.2    Worldwide Growing Breast Cancer Cases

    26.3    Reclassification of Mammography Equipment by FDA


    27.    Breast Cancer Screening Market Challenges
     27.1    Difference of Opinion on Breast Cancer Mammography Screening

    27.2    Societal and Cultural Barriers for Breast Cancer Screening
      

    List of Figures:

    Figure 2–1: Worldwide – Breast Cancer Mammography Screening Population (Million), 2010 – 2016
    Figure 2–2: Worldwide – Forecast for Breast Cancer Mammography Screening Population (Million), 2017 – 2022
    Figure 2–3: Worldwide – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 2–4: Worldwide – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022

    Figure 3–1: Worldwide – Breast Cancer Screening Market (Billion US$), 2010 – 2016
    Figure 3–2: Worldwide – Forecast for Breast Cancer Screening Market (Billion US$), 2017 – 2022
    Figure 3–3: Worldwide – Breast Cancer Mammography Screening Market (Billion US$), 2010 – 2016
    Figure 3–4: Worldwide – Forecast for Breast Cancer Mammography Screening Market (Billion US$), 2017 – 2022
    Figure 3–5: Worldwide – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 3–6: Worldwide – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 3–7: Worldwide – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 3–8: Worldwide – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 6–1: United Kingdom – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 6–2: United Kingdom – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 6–3: United Kingdom – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 6–4: United Kingdom – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 6–5: United Kingdom – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 6–6: United Kingdom – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 6–7: United Kingdom – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 6–8: United Kingdom – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 6–9: United Kingdom – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 6–10: United Kingdom – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 6–11: United Kingdom – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 6–12: United Kingdom – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 7–1: France – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 7–2: France – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 7–3: France – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 7–4: France – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 7–5: France – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 7–6: France – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 7–7: France – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 7–8: France – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 7–9: France – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 7–10: France – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 7–11: France – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 7–12: France – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 8–1: Germany – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 8–2: Germany – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 8–3: Germany – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 8–4: Germany – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 8–5: Germany – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 8–6: Germany – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 8–7: Germany – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 8–8: Germany – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 8–9: Germany – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 8–10: Germany – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 8–11: Germany – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 8–12: Germany – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 9–1: Italy – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 9–2: Italy – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 9–3: Italy – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 9–4: Italy – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 9–5: Italy – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 9–6: Italy – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 9–7: Italy – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 9–8: Italy – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 9–9: Italy – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 9–10: Italy – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 9–11: Italy – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 9–12: Italy – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 10–1: Spain – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 10–2: Spain – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 10–3: Spain – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 10–4: Spain – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 10–5: Spain – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 10–6: Spain – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 10–7: Spain – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 10–8: Spain – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 10–9: Spain – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 10–10: Spain – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 10–11: Spain – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 10–12: Spain – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 11–1: Switzerland – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 11–2: Switzerland – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 11–3: Switzerland – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 11–4: Switzerland – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 11–5: Switzerland – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 11–6: Switzerland – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 11–7: Switzerland – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 11–8: Switzerland – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 11–9: Switzerland – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
    Figure 11–10: Switzerland – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
    Figure 11–11: Switzerland – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
    Figure 11–12: Switzerland – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022

    Figure 12–1: Norway – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 12–2: Norway – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 12–3: Norway – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 12–4: Norway – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 12–5: Norway – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 12–6: Norway – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 12–7: Norway – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 12–8: Norway – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 12–9: Norway – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
    Figure 12–10: Norway – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
    Figure 12–11: Norway – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
    Figure 12–12: Norway – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022

    Figure 13–1: Netherlands – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 13–2: Netherlands – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 13–3: Netherlands – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 13–4: Netherlands – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 13–5: Netherlands – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 13–6: Netherlands – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 13–7: Netherlands – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 13–8: Netherlands – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 13–9: Netherlands – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 13–10: Netherlands – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 13–11: Netherlands – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 13–12: Netherlands – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 14–1: United States – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 14–2: United States – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 14–3: United States – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 14–4: United States – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 14–5: United States – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 14–6: United States – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 14–7: United States – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 14–8: United States – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 14–9: United States – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 14–10: United States – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 14–11: United States – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 14–12: United States – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 15–1: Canada – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 15–2: Canada – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 15–3: Canada – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 15–4: Canada – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 15–5: Canada – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 15–6: Canada – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 15–7: Canada – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 15–8: Canada – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 15–9: Canada – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 15–10: Canada – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 15–11: Canada – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 15–12: Canada – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 16–1: Japan – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 16–2: Japan – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 16–3: Japan – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 16–4: Japan – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 16–5: Japan – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 16–6: Japan – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 16–7: Japan – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 16–8: Japan – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 16–9: Japan – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
    Figure 16–10: Japan – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
    Figure 16–11: Japan – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
    Figure 16–12: Japan – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022

    Figure 17–1: Korea – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 17–2: Korea – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 17–3: Korea – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 17–4: Korea – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 17–5: Korea – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 17–6: Korea – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 17–7: Korea – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 17–8: Korea – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 17–9: Korea – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
    Figure 17–10: Korea – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
    Figure 17–11: Korea – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
    Figure 17–12: Korea – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022

    Figure 18–1: Singapore – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 18–2: Singapore – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 18–3: Singapore – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 18–4: Singapore – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 18–5: Singapore – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 18–6: Singapore – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 18–7: Singapore – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 18–8: Singapore – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 18–9: Singapore – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
    Figure 18–10: Singapore – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
    Figure 18–11: Singapore – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
    Figure 18–12: Singapore – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022

    Figure 19–1: Malaysia – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 19–2: Malaysia – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 19–3: Malaysia – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 19–4: Malaysia – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 19–5: Malaysia – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 19–6: Malaysia – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 19–7: Malaysia – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 19–8: Malaysia – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 19–9: Malaysia – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
    Figure 19–10: Malaysia – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
    Figure 19–11: Malaysia – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
    Figure 19–12: Malaysia – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022

    Figure 20–1: India – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 20–2: India – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 20–3: India – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 20–4: India – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 20–5: India – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 20–6: India – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 20–7: India – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 20–8: India – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 20–9: India – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 20–10: India – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 20–11: India – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 20–12: India – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 21–1: China – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 21–2: China – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 21–3: China – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 21–4: China – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 21–5: China – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 21–6: China – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 21–7: China – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 21–8: China – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 21–9: China – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 21–10: China – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 21–11: China – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 21–12: China – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 22–1: Thailand – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 22–2: Thailand – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 22–3: Thailand – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 22–4: Thailand – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 22–5: Thailand – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 22–6: Thailand – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 22–7: Thailand – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 22–8: Thailand – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 22–9: Thailand – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
    Figure 22–10: Thailand – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
    Figure 22–11: Thailand – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
    Figure 22–12: Thailand – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022

    Figure 23–1: Brazil – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 23–2: Brazil – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 23–3: Brazil – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 23–4: Brazil – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 23–5: Brazil – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 23–6: Brazil – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 23–7: Brazil – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 23–8: Brazil – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 23–9: Brazil – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 23–10: Brazil – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 23–11: Brazil – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 23–12: Brazil – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 24–1: Australia – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 24–2: Australia – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 24–3: Australia – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 24–4: Australia – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 24–5: Australia – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 24–6: Australia – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 24–7: Australia – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 24–8: Australia – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 24–9: Australia – Breast Cancer MRI Screening Market (Million US$), 2010 – 2016
    Figure 24–10: Australia – Forecast for Breast Cancer MRI Screening Market (Million US$), 2017 – 2022
    Figure 24–11: Australia – Breast Cancer Ultrasound Screening Market (Million US$), 2010 – 2016
    Figure 24–12: Australia – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2017 – 2022

    Figure 25–1: New Zealand – Breast Cancer Mammography Screening Population (Thousand), 2010 – 2016
    Figure 25–2: New Zealand – Forecast for Breast Cancer Mammography Screening Population (Thousand), 2017 – 2022
    Figure 25–3: New Zealand – Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2010 – 2016
    Figure 25–4: New Zealand – Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2017 – 2022
    Figure 25–5: New Zealand – Breast Cancer Screening Market (Million US$), 2010 – 2016
    Figure 25–6: New Zealand – Forecast for Breast Cancer Screening Market (Million US$), 2017 – 2022
    Figure 25–7: New Zealand – Breast Cancer Mammography Screening Market (Million US$), 2010 – 2016
    Figure 25–8: New Zealand – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2017 – 2022
    Figure 25–9: New Zealand – Breast Cancer MRI Screening Market (Thousand US$), 2010 – 2016
    Figure 25–10: New Zealand – Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2017 – 2022
    Figure 25–11: New Zealand – Breast Cancer Ultrasound Screening Market (Thousand US$), 2010 – 2016
    Figure 25–12: New Zealand – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2017 – 2022


    List of Tables:

    Table 4–1: Worldwide – Breast Cancer Mammography Screening Population Share (Percent), 2010 – 2016
    Table 4–2: Worldwide – Forecast for Breast Cancer Mammography Screening Population Share (Percent), 2017 – 2022
    Table 4–3: Worldwide – Breast Cancer MRI & Ultrasound Screening Population Share (Percent), 2010 – 2016
    Table 4–4: Worldwide – Forecast for Breast Cancer MRI & Ultrasound Screening Population Share (Percent), 2017 – 2022

    Table 5–1: Worldwide – Breast Cancer Screening Market Share (Percent), 2010 – 2016
    Table 5–2: Worldwide – Forecast for Breast Cancer Screening Market Share (Percent), 2017 – 2022
    Table 5–3: Worldwide – Breast Cancer Mammography Screening Market Share (Percent), 2010 – 2016
    Table 5–4: Worldwide – Forecast for Breast Cancer Mammography Screening Market Share (Percent), 2017 – 2022
    Table 5–5: Worldwide – Breast Cancer MRI Screening Market Share (Percent), 2010 – 2016
    Table 5–6: Worldwide – Forecast for Breast Cancer MRI Screening Market Share (Percent), 2017 – 2022
    Table 5–7: Worldwide – Breast Cancer Ultrasound Screening Market Share (Percent), 2010 – 2016
    Table 5–8: Worldwide – Forecast for Breast Cancer Ultrasound Screening Market Share (Percent), 2017 – 2022

    Table 26–1: Worldwide – Breast cancer Incidence Rate (Number), 2008 & 2012
    Table 26–2: Worldwide – Breast cancer Mortality Rate (Number), 2012

    • Description
      Price
    • Chapter 1 & 2     Pages : 28
      $400
    • Chapter 3     Pages : 7
      $400
    • Chapter 4     Pages : 5
      $400
    • Chapter 5     Pages : 10
      $400
    • Chapter 6     Pages : 10
      $200
    • Chapter 7     Pages : 9
      $200
    • Chapter 8     Pages : 10
      $200
    • Chapter 9     Pages : 9
      $200
    • Chapter 10     Pages : 9
      $200
    • Chapter 11     Pages : 10
      $200
    • Chapter 12     Pages : 10
      $200
    • Chapter 13     Pages : 9
      $200
    • Chapter 14     Pages : 10
      $200
    • Chapter 15     Pages : 11
      $200
    • Chapter 16     Pages : 9
      $200
    • Chapter 17     Pages : 11
      $200
    • Chapter 18     Pages : 9
      $200
    • Chapter 19     Pages : 10
      $200
    • Chapter 20     Pages : 10
      $200
    • Chapter 21     Pages : 10
      $200
    • Chapter 22     Pages : 9
      $200
    • Chapter 22     Pages : 10
      $200
    • Chapter 23     Pages : 11
      $200
    • Chapter 24     Pages : 10
      $200
    • Chapter 25     Pages : 7
      $200
    • Chapter 26     Pages : 2
      $200

    Related Products